OVERVIEW

Prescribing Practices and Management of Chronic Pain and Substance Abuse Disorder CME Course is organized by Western Institute of Legal Medicine (WILM) and will be held from Mar 21 - 22, 2026.

Description:
This accredited Continuing Medical Course (CME) on Prescribing Practices and Management of Chronic Pain and Substance Abuse Disorder is an intensive 2-day live CME Course designed for physicians, dentists, nurse practitioners, physician assistants, and other healthcare professionals in all medical specialties who need or wish to increase their clinical knowledge and ability to effectively and safely prescribe Scheduled Controlled Substances, Opioids, and other dangerous prescription medications while reducing the risk for abuse.

This CME Course covers topics such as choosing medications, proper dosing, chronic pain diagnosis, prescribing and treatment, improper medication orders, and common bases for actions by regulatory agencies relating to medications.

Research indicates that up to one third of the disciplinary actions taken by Medical Boards are related to physician misprescribing practices. Learn proper prescribing practices and how best to document prescriptions for controlled substances. Learn to avoid common pitfalls including: inappropriate dispensing of medications from physician’s offices, prescribing large amounts of narcotics at frequent intervals, or prescribing to family members, friends, or a person with a known history of substance abuse.

At the conclusion of this activity, participants should be able to:

  • Identify and prevent the common causes of prescribing-related patient injury.
  • Integrate satisfaction of patients and families with medication treatment.
  • Recognize and protect patients’ legal rights such as informed consent relating to medications.
  • Recognize and comply with clinicians’ legal responsibilities relating to medications.
  • Integrate supervision by physicians of mid-level practitioners who prescribe or monitor medication therapy.
  • Illustrate cooperation among members of the health care team relating to medications.

KEY DATES

Event Start Date
21 Mar, 2026
Event Start Date
Event End Date
22 Mar, 2026
Event End Date
Credits

Accreditation Statement:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of California, Irvine School of Medicine and Western Institute of Legal Medicine. The University of California, Irvine School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement:
The University of California, Irvine School of Medicine designates this live activity for a maximum of up to 21 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 21 AMA PRA Category 1 Credits™
  • 21 CME
  • TARGET AUDIENCE

    PhysicianNursingDentistPhysician AssistantNursesNurse PractitionersOther Health Professionals

    SPECIALITIES

    Clinical PsychologyChronic DiseasesPsychiatry

    RELATED CONFERENCES & LIVE WEBINARS